Estradiol Benzoate: High-Affinity Estrogen Receptor Alpha Agonist for Advanced Research

Executive Summary: Estradiol Benzoate (SKU B1941) is a synthetic estradiol analog with high affinity for estrogen receptor alpha (ERα), exhibiting an IC50 of 22–28 nM in human, murine, and avian models (APExBIO). The compound is insoluble in water but dissolves well in DMSO (≥12.15 mg/mL) and ethanol (≥9.6 mg/mL) under standard laboratory conditions. It is supplied at ≥98% purity, validated by HPLC, MS, and NMR, and is intended strictly for research use. Estradiol Benzoate is routinely employed in estrogen receptor signaling research, hormone receptor binding assays, and in studies on hormone-dependent cancers (Vijayan et al., 2021). APExBIO provides detailed QC documentation and workflow support for reliable experimental integration.

Biological Rationale

Estradiol Benzoate is designed as a synthetic analog of 17β-estradiol, the principal endogenous estrogen in vertebrates. It acts as a high-affinity agonist of estrogen receptor alpha (ERα), a nuclear hormone receptor involved in the regulation of gene expression, cell proliferation, and differentiation across numerous tissues (APExBIO). In both mammalian and avian systems, ERα is a critical mediator of estrogenic signaling, modulating transcriptional responses to hormonal fluctuations. Estradiol Benzoate's chemical structure (C25H28O3, MW 376.49 g/mol) enables consistent receptor engagement and experimental reproducibility. Its role extends to progestogen receptor activation, supporting combinatorial studies in hormone biology. The compound's defined physical properties ensure compatibility with organic solvent-based assay systems used in cell-based and biochemical research. By providing a robust tool for dissecting estrogen receptor-mediated pathways, Estradiol Benzoate facilitates research in endocrinology, reproductive biology, and hormone-dependent malignancies (See contrast: This article updates mechanistic depth beyond standard overviews).

Mechanism of Action of Estradiol Benzoate

Estradiol Benzoate binds with nanomolar affinity to ERα, displacing endogenous estradiol and initiating conformational changes that promote receptor dimerization and DNA binding. This binding event triggers the transcription of estrogen-responsive genes involved in cellular growth and differentiation. In parallel, Estradiol Benzoate can activate progestogen receptors, enabling analysis of cross-talk between steroid hormone pathways. The compound's benzoate esterification confers increased metabolic stability in vitro, optimizing its use in extended cell culture and binding assays. Its high selectivity for ERα over other nuclear receptors reduces confounding off-target effects, supporting clear interpretation of experimental outcomes. The standardized IC50 range (22–28 nM) facilitates direct comparison across published and in-house datasets (Extends: Explores translational and competitive positioning for clinical relevance).

Evidence & Benchmarks

• Estradiol Benzoate exhibits an IC50 of 22–28 nM for ERα in human, mouse, and chicken models, supporting its use in cross-species estrogen receptor research (APExBIO).
• Compound purity is validated at ≥98% by high-performance liquid chromatography (HPLC), mass spectrometry (MS), and nuclear magnetic resonance (NMR) analyses (APExBIO QC data).
• Estradiol Benzoate demonstrates solubility ≥12.15 mg/mL in dimethyl sulfoxide (DMSO) and ≥9.6 mg/mL in ethanol at 20–25°C, but is insoluble in water (APExBIO).
• Short-term solutions are stable at -20°C; extended storage or repeated freeze-thaw cycles may degrade compound integrity (APExBIO Storage Guide).
• Estradiol Benzoate is routinely applied in hormone receptor binding assays and in studies of estrogen receptor-mediated signaling in hormone-dependent cancers (Vijayan et al., 2021).
• Internal scenario-driven studies highlight Estradiol Benzoate's reproducibility and workflow compatibility for cell viability and proliferation assays (Clarifies: Offers practical protocols beyond standard product information).

Applications, Limits & Misconceptions

Estradiol Benzoate is validated for use in:

• Estrogen receptor signaling research, including mechanistic pathway analysis.
• Hormone receptor binding assays to quantify ligand-receptor interactions.
• Cell viability and proliferation studies in endocrine and hormone-dependent cancer models.
• Comparative research across vertebrate systems due to its conserved receptor affinity.

However, Estradiol Benzoate is not intended for diagnostic or therapeutic use in humans or animals. It is not soluble in water, limiting its use in purely aqueous systems. Degradation may occur if stored above -20°C or subjected to repeated freeze-thaw cycles. Cross-reactivity with other steroid receptors is minimal but not entirely absent—researchers should validate specificity in each model.

Common Pitfalls or Misconceptions

• Estradiol Benzoate is not suitable for in vivo therapeutic applications or clinical diagnosis.
• It should not be used in aqueous-only buffers due to insolubility; DMSO or ethanol are required for dissolution.
• Long-term storage of prepared solutions is discouraged; degradation may impair activity.
• Batch-to-batch purity should always be confirmed with provided QC data to ensure experimental reproducibility.
• Estradiol Benzoate may not fully recapitulate endogenous estradiol dynamics due to its esterified structure and altered metabolic fate.

Workflow Integration & Parameters

Estradiol Benzoate is provided by APExBIO as a high-purity, solid compound, shipped with blue ice to maintain stability. For preparation, dissolve in DMSO or ethanol to the desired stock concentration (typically 10–20 mM). Working solutions should be freshly prepared and kept at -20°C for short-term use. Recommended application concentrations in cell-based assays range from 1 nM to 1 μM, depending on cell type and experimental design. Validation of receptor activation should be confirmed via downstream gene expression (e.g., qPCR of estrogen-responsive transcripts) or reporter assays. For hormone receptor binding studies, competitive displacement protocols using radiolabeled or fluorescent ligands are recommended. Batch-specific QC certificates (HPLC, MS, NMR) are supplied for every lot. For practical troubleshooting and scenario-based guidance, refer to this workflow-focused article, which expands on real-world laboratory integration.

Conclusion & Outlook

Estradiol Benzoate (SKU B1941) remains a foundational reagent for advanced estrogen receptor alpha signaling research, hormone receptor binding assays, and studies of hormone-dependent diseases. Its well-characterized affinity, defined solubility, and validated purity support reproducible and interpretable results. As research expands into combinatorial steroid signaling and precision endocrinology, Estradiol Benzoate's standardized properties and rigorous quality control ensure continued relevance. For ordering and full documentation, visit the Estradiol Benzoate product page at APExBIO.